Filter Results:
(3,409)
Show Results For
- All HBS Web
(3,409)
- People (9)
- News (719)
- Research (2,190)
- Events (38)
- Multimedia (28)
- Faculty Publications (1,291)
Show Results For
- All HBS Web
(3,409)
- People (9)
- News (719)
- Research (2,190)
- Events (38)
- Multimedia (28)
- Faculty Publications (1,291)
- 02 Mar 2012
- HBS Seminar
Joe Lassiter/Gordon Jones, Harvard Business School/Harvard University
- Research Summary
Overview
By: Vincent Pons
Professor Pons studies questions in political economy and development with the goal of understanding how democratic systems function, and how they can be improved.
He decomposes the electoral cycle into four essential steps: the factors affecting voter... View Details
He decomposes the electoral cycle into four essential steps: the factors affecting voter... View Details
- Research Summary
Overview
My focus is empirical financial accounting research, with particular interests in governance, valuation, M&A, and short-sellers. All three of my papers to date fall under the broad heading of “alternative governance mechanisms”—studies of how accounting information is... View Details
- Research Summary
Overview
My focus is empirical financial accounting research, with particular interests in governance, valuation, M&A, and short-sellers. All three of my papers to date fall under the broad heading of “alternative governance mechanisms”—studies of how accounting information is... View Details
- 01 Jun 2023
- News
Research Brief: The Best Medicine
the clinical approval process. In a survey experiment, the researchers found that 72 percent of doctors had been asked by their patients whether a new drug would “work in people like me.” Black patients and the doctors who treat them put less faith in trial evidence... View Details
- 16 Sep 2016
- News
Gaining Ground on ALS
1998. “But this grant is significant because it facilitates the sharing of plasma samples, collected from test subjects over time, with academic researchers.” The collaboration is a first for an international, late-stage trial and could... View Details
- 24 Sep 2020
- News
The Race for a Vaccine
Moderna could create a vaccine for clinical testing in just 60 days. That was three times faster than any vaccine candidate had ever been produced. Fauci didn't believe him. An idea emerged to test Bancel’s... View Details
- Article
Quantifying the Use of Connected Digital Products in Clinical Research
By: Caroline Marra, Jacqueline L. Chen, Andrea Coravos and Ariel D. Stern
Over recent years, the adoption of connected technologies has grown dramatically, with potential for improving health care delivery, research, and patient experience. Yet, little has been documented about the prevalence and use of connected digital products (e.g.,... View Details
Keywords: Connected Digital Products; Clinical Trials; Health Testing and Trials; Information Technology; Research
Marra, Caroline, Jacqueline L. Chen, Andrea Coravos, and Ariel D. Stern. "Quantifying the Use of Connected Digital Products in Clinical Research." Art. 50. npj Digital Medicine 3 (2020).
- 15 Jun 2004
- Conference Presentation
What is the Best Measure of Adiposity for Predicting Testosterone? Results from the Massachusetts Male Aging Study
By: William B. Simpson, Frances J. Hayes, Andre B. Araujo and John B. McKinlay
Keywords: Measurement and Metrics; Health Testing and Trials; Age Characteristics; Gender Characteristics; Massachusetts
Simpson, William B., Frances J. Hayes, Andre B. Araujo, and John B. McKinlay. "What is the Best Measure of Adiposity for Predicting Testosterone? Results from the Massachusetts Male Aging Study." Paper presented at the Enocrine Society Annual Meeting, New Orleans, LA, June 15, 2004.
- 28 Jan 2016
- News
Harvard Business School Launches Precision Trials Challenge
- Research Summary
Research Thrust
By: Rakesh Khurana
I am trained in organizational sociology and my main areas of interest lie in macro-organizational theory and the dynamics of executive labor markets. To date, my research has focused on two themes. The first revolves around understanding the forces that govern the... View Details
- 03 Jun 2020
- Research & Ideas
Who Guarantees Your Workplace Is Safe for Return?
50-60 percent recommended to minimize viral transmission. Sensors: Air quality and other measurable conditions. While it’s not currently possible to test directly for coronaviruses in the air, other measures like particulate counts,... View Details
- 08 Mar 2018
- Cold Call Podcast
Could a New Business Model Make Clinical Drug Trials More Accessible to Patients?
Keywords: Health
- September 2008
- Background Note
Background on the Technology of Molecular Diagnostics
By: Regina E. Herzlinger and Jason Sanders
To be used as background reading for the "EXACT Sciences Corp.: Commercializing a Diagnostic Test" and "Diagnostic Genomics" cases, HBS nos. 308-090 and 309-040. View Details
Keywords: Health Testing and Trials; Technology; Biotechnology Industry; Medical Devices and Supplies Industry
Herzlinger, Regina E., and Jason Sanders. "Background on the Technology of Molecular Diagnostics." Harvard Business School Background Note 309-050, September 2008.
- 05 Nov 2009
- Research & Ideas
A Market for Human Cadavers in All but Name?
(Editor's Note: In a recent issue, Economic Sociology: The European Electronic Newsletter tackled the controversial issue of "commodification of the body." Harvard Business School professor Michel Anteby contributed the following essay that discusses issues... View Details
- 15 Jan 2021
- News
To Overcome Vaccine Hesitancy, We Need a Better Patient Experience
- 14 May 2020
- News
Perspectives in Health: Everlywell, Diagnostics and COVID
- 19 Apr 2016
- News
LuminOva Makes Great Strides Tackling Infertility
Alexandra Dickson (MBA 2013) Alexandra Dickson (MBA 2013) LuminOva, a biotech startup in Boston that won the 2015 Bertarelli Prize, is making progress on its quest to develop a new technology that could increase in vitro fertilization success rates by monitoring the... View Details
- 13 Oct 2016
- News
Adding Muscle to the Fight Against Disease
hundreds of millions of dollars, the ALS grant to Cytokinetics is significant because it facilitates the collection of plasma samples from test subjects over an extended period of time. The samples will be shared with academic... View Details
Keywords: Deborah Blagg
- December 2014 (Revised August 2015)
- Case
Improving Melanoma Screening: MELA Sciences
By: Regina E. Herzlinger, Kevin Schulman and Frédéric Dijols
MELA is a start-up medical device company looking to develop a novel technology to help physicians diagnose a deadly skin cancer, melanoma. The case reviews the FDA medical device development process, the development path pursued by MELA, and the regulatory and... View Details